Boston Scientific Cross-Appeals Stent Patent Ruling

By Julie Zeveloff

Law360, New York (March 03, 2010, 2:15 PM ET) -- Weeks after Johnson & Johnson Inc. appealed a federal court's ruling that four of its patents for drug-eluting stents are invalid, Boston Scientific Corp. has notified the court that it will also appeal parts of that case.

BSC lodged a notice of cross-appeal Tuesday in the U.S. District Court for the District of Delaware, saying it would ask the U.S. Court of Appeals for the Federal Circuit to reconsider all underlying opinions, orders and rulings adverse to BSC, including certain claim limitations construed in a Jan....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles